In this Issue
How are reoccuring lesions in the SFA best treated and managed?
CHIEF MEDICAL EDITOR'S PAGE
By John R. Laird, MD
Mechanisms, incidence, treatment, and outcomes of in-stent restenosis in the iliac and femoropopliteal arteries.
By Satinder Singh, MD; Ehrin J. Armstrong, MD; and John R. Laird, MD
The cost of freedom from restenosis and repeat intervention.
By Mark W. Burket, MD
What is your go-to option for treating in-stent restenosis?
With Antonio Micari, MD, PhD; Prof. Dr. med. Nicolas Diehm; Michael H. Wholey, MD, MBA; Jos C. van den Berg, MD, PhD; and Andrew J. Feiring, MD, FACC, FSCAI, FAHA
Available data show promising results for treating in-stent restenosis in the superficial femoral artery.
By Eugenio Stabile, MD, PhD, and Vittorio Virga, MD
A review of the current data on the role of atherectomy devices in debulking these difficult lesions.
By Eric J. Dippel, MD, FACC, and Nicolas W. Shammas, MD, MS, FACC
Peter A. Soukas, MD, discusses the available data, his clinical experiences, and techniques for better outcomes and restenosis prevention.
The role of cilostazol in the treatment of patients with infrainguinal lesions.
By Osamu Iida, MD, and Yoshimitsu Soga, MD
Separating apples from oranges while identifying the picked cherries: a look at the factors to consider before drawing conclusions.
By Michael R. Jaff, DO
VESSEL UPDATE: PROSTATIC ARTERY
Nigel Hacking, BSc, MBBS, FRCP, FRCR, shares his experience in treating benign prostatic hypertrophy using the latest interventional embolic techniques.
A case report that supports smaller sheath sizes to minimize access site bleeding during percutaneous peripheral vascular intervention.
By Erik Stilp, MD; Jacqueline Gamberdella, BS; and Carlos Mena-Hurtado, MD, FACC, FSCAI
CODING & REIMBURSEMENT
An explanation of what is included in both the diagnostic and the interventional codes and how to properly report the services provided.
By Katharine Krol, MD, FSIR, FACR
A preview of today’s new products.
An esteemed vascular surgeon discusses aortic aneurysm treatment technologies and follow-up methods, focusing on the need for individualized patient care.